Medical News

RSS

Crooks defraud health care system with fake insurance plans and phony Medicare, Medicaid claims

"Massive unemployment and a changing health care system is creating a breeding ground for con artists." Fake health insurance is one of the "fastest growing scams." Advertisements for such products are "stapled to neighborhood telephone polls, flyers left on your car or maybe you'll get a phone call from someone who's selling health insurance at extremely low rates, as low as $29.99 a month in some cases, says Jim Quiggle of the Coalition Against Insurance Fraud. The sad truth is that often these bogus policies pay little or nothing on claims, leaving consumers with exorbitant medical bills" (Haley, 7/6).

8 Jul 2010

Common glucose test accurately predicts Type II adult-onset diabetes, study finds

A common test to diagnose gestational diabetes -- a temporary condition which can harm both mother and child if left untreated -- also has predictive power for Type II adult-onset diabetes, a new Tel Aviv University study finds.

8 Jul 2010

Australian health makeover over the next few years planned

Australian health is about to get a massive make over according to the four year time schedule and plans announced by the Federal Government. The plans include major reforms that will be undertaken over the next two years.

7 Jul 2010

In depth look at Victorian ambulance services before November

After quite a few cases of delayed ambulance services the Victorian Auditor-General has now agreed to have an in-depth look at Victoria's ambulance services before the November state election. This is in response to a communication made by the State Opposition earlier this year.

7 Jul 2010

Brain fever mistaken as migraine kills a 30 year old woman

Jane Harrop, a 30 year old British woman was complaining of headaches for several days that made her feel “drunk”. She was diagnosed to be suffering from migraine but died two days later from a viral infection of the brain.

7 Jul 2010

Patent issued for jellyfish protein for therapeutic application

Quincy Bioscience, a research-based biotechnology company, announced the issuance of United States patent No.7,671,015. The patent covers the use of aequorin-containing compounds for the purpose of preventing and alleviating symptoms and disorders related to calcium imbalance.

7 Jul 2010

San Diego's Sharp Memorial Hospital named America's Most Beautiful Hospital

Soliant Health, a leading specialty healthcare staffing provider and part of Adecco Group, is proud to announce that San Diego's Sharp Memorial Hospital was named America's Most Beautiful Hospital by Soliant.com visitors.

7 Jul 2010

NOXXON to commence multiple ascending dose study of MCP-1 targeting anti-inflammatory Spiegelmer NOX-E36

NOXXON Pharma AG announced today that it has permission to commence a multiple ascending dose study of its Monocyte Chemoattractant Protein-1 (MCP-1) targeting anti-inflammatory Spiegelmer®, NOX-E36. NOXXON plans to develop NOX-E36 for the treatment of diabetic nephropathy and other diabetes related complications.

7 Jul 2010

Wichita Clinic plans to implement Centricity EMR solutions from GE Healthcare

With more than 160 doctors covering 40 specialty care areas, Kansas' largest physician-owned practice is the latest to choose GE Centricity solutions to help drive patient care enhancements and cost reductions.

7 Jul 2010

ISCO and Sankara Nethralaya collaborate to develop "CytoCor" stem cell-derived corneal tissue

International Stem Cell Corporation and Sankara Nethralaya, announced today commencement of a collaboration to develop ISCO's "CytoCor™" stem cell-derived corneal tissue. The goal is to use CytoCor to treat corneal blindness and vision impairment. "This is one more step in ISCO's stated plan of building its portfolio of therapeutic agents through strategic alliances throughout the world," said Chairman, Ken Aldrich.

7 Jul 2010

Testimony on importance of addressing health literacy in healthcare communications released

Health Dialog today released testimony on the importance of addressing health literacy in healthcare communications. The testimony was presented before the ERISA Advisory Council during a hearing on July 1, 2010. The council advises the U.S. Secretary of Labor on a number of employee benefits-related issues.

7 Jul 2010

Uptake Medical completes Series B financing led by Maverick Capital

Uptake Medical, a privately held interventional pulmonology company, announced today that it has concluded its Series B financing from an investment group led by Maverick Capital, a new investor. The company plans to use this capital to obtain the CE mark and introduce its unique proprietary Bronchoscopic Thermal Vapor Ablation (BTVA) technology outside of the U.S. The company also has begun its approval cycle with the FDA in the U.S.

7 Jul 2010

Winston submits NDA for CIVANEX to U.S. FDA

Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc., a pharmaceutical company focused on developing and commercializing novel pain management therapies, announced that it has submitted a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for approval to market its civamide (zucapsaicin) 0.075% cream, CIVANEX®, for the treatment of signs and symptoms of osteoarthritis of the knee.

7 Jul 2010

FDA grants orphan drug designation for Synageva BioPharma's SBC-102

Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.

7 Jul 2010

Neoprobe initiates third multi-center Phase 3 clinical study of Lymphoseek

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that a third multi-center Phase 3 clinical study of Lymphoseek (NEO3-09) has received investigational review board approval and begun enrollment of subjects diagnosed with breast cancer or melanoma.

7 Jul 2010

Opsens third-quarter revenues increase 15% to $1,469,000

Opsens Inc. today released its financial results for the three- and nine-month periods ended May 31, 2010.

7 Jul 2010

Biomerics enters into strategic partnership with Diamond Mold

Biomerics, a leader and innovator of medical polymer solutions, announced today that it has entered into a strategic partnership with Diamond Mold, of Salt Lake City, Utah.

7 Jul 2010

Skilled Healthcare Group to challenge Humboldt County verdict

Skilled Healthcare Group, Inc. today reported that a jury in Humboldt County, California, returned a verdict against the Company related to a complaint filed more than four years ago. The case has been disclosed in the Company's prior Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K.

7 Jul 2010

Method of suicide attempt predicts subsequent successful suicide: Study

The method used for a suicide attempt is highly significant for the risk of subsequent successful suicide, reveals a long-term study from Karolinska Institutet. The results may be of help in acute risk assessment following a suicide attempt.

7 Jul 2010

SDI Pharmaceutical Company Image 2010 study: Novo Nordisk ranked top among endocrinologists

According to SDI's Pharmaceutical Company Image 2010 study, Novo Nordisk was ranked by endocrinologists as the top company overall. The company was mentioned by 62% of the endocrinologists who participated in the annual study - a substantial increase from last year, when it was mentioned by 52% of participants and ranked second.

7 Jul 2010